Detailed guide on Apple's F1 strategy: streaming rights, movie sequel, executive passion, services integration, with common mistakes and actionable steps for 2026.
New blood test detects arsenic exposure via DNA marker, predicts chronic disease risk for 200M+ people worldwide.
MD Anderson's RF-SIRF maps reversed DNA replication forks in single cells, revealing an epigenetic code for replication stress tied to cancer, aging, and treatment response.
Explore the threats to the American Dream—rising costs, low voter turnout, and wealth inequality—and learn about immediate donations and long-term pledges to restore opportunity for all.
A new blood DNA methylation marker accurately tracks chronic arsenic exposure and may predict risk of cancer and heart disease, enabling early intervention for millions.
A new imaging method called RF-SIRF reveals reversed DNA replication forks in single cells, uncovering an epigenetic code for replication stress with implications for genomic stability, aging, and cancer treatment.
GitHub's defensive rate limits outlived their purpose, blocking legitimate users. Learn the causes, user impact, and five key lessons for managing security systems at scale.
Learn to repurpose recommendation algorithm AI for drug discovery. Step-by-step guide from defining 'undruggable' targets to validating AI-designed therapies, with tips and prerequisites.
A blood-based DNA methylation biomarker can track long-term arsenic exposure and predict toxicity risk, offering a non-invasive screening tool for over 200 million people.
Scientists discovered a blood-based DNA marker that tracks arsenic exposure and may predict toxicity risk, offering a new tool for the over 200 million people exposed globally.
A guide to scaling bespoke genetic therapies, based on the story of Mila and the lessons from EveryONE Medicines, covering prerequisites, step-by-step development, and common pitfalls.
Understand FDA’s PFAS findings in baby formula: levels are extremely low (≤2.9 ppt), supply is safe. Steps to reduce exposure and common misconceptions explained.
Learn how historical inequities and modern barriers exclude people of color from psychedelic therapy, and discover actionable steps to advocate for inclusion.
A step-by-step tutorial on obtaining FDA approval for Alzheimer's agitation drugs, using Axsome's recent milestone as a case study. Covers prerequisites, trial phases, regulatory interactions, and common mistakes.
Learn how to effectively read, react, and submit Letters to the Editor to STAT's First Opinion platform, with step-by-step tips and common pitfalls to avoid.
Expert guide to the 5th Circuit's ruling blocking mailing of mifepristone. Covers overview, prerequisites, step-by-step analysis, common mistakes, and summary.
Scientists discover rare flavoalkaloids in cannabis leaves with potential health benefits, challenging previous assumptions about the plant's waste products.
New DNA-based therapy blocks PCSK9 protein, cutting LDL cholesterol nearly 50% without statins, offering breakthrough alternative for heart disease prevention.
New study reveals abdominal muscle movements trigger brain sway that boosts cerebrospinal fluid circulation, potentially flushing out waste linked to Alzheimer’s.
Scientists warn that deadly amoebas are spreading globally due to climate change and outdated water systems. Urgent surveillance and improved treatment are needed to prevent rising infections.